Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
University of Virginia
Eli Lilly and Company
Mayo Clinic
University of California, San Francisco
Eli Lilly and Company
City of Hope Medical Center
Syros Pharmaceuticals
Case Comprehensive Cancer Center
Gossamer Bio Inc.
Bayer
AstraZeneca
Gilead Sciences
Celgene
University of Chicago
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Northwestern University
Altor BioScience
Piramal Enterprises Limited
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Center, Korea